novo nordisk glp-1 receptor agonist weight management diabetes treatments Ozempic's patent problem: how lost control of a blockbuster drug. 💉 Demand for weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite How GLP-1 Receptor Agonists Evolved

Future clinical trials should aim to distinguish the direct analgesic effects of GLP-1RAs from their metabolic benefits and explore their broader applications in pain conditions

Though GLP-1RAs are increasingly being prescribed for off-label uses, more than nine in 10 of the physicians surveyed across all specialties have prescribed a GLP-1RA medication for weight loss

GLP-1 Injections: The Established Gold Standard For most patients in the UK, GLP-1 injections are the most recognisable form of this treatment

No wonder payers are concerned about the short- and long-term costs

This encouraged scientists to begin investigating whether targeting the central nervous system could provide an effective strategy for weight loss (Capozzi, DiMarchi, Tschpp)

GIP activation may also provide complimentary mechanisms by potentiating the expansion of white adipose tissue and lipid handling [13]